Results 191 to 200 of about 3,812,042 (342)

ANNALS OF CAMBRIDGE UNIVERSITY LIBRARY [PDF]

, 1915
Charles Sayle
openalex   +1 more source

MicroRNA 196a contributes to the aggressiveness of esophageal adenocarcinoma through the MYC/TERT/NFκB axis

Molecular Oncology, EarlyView.
mir‐196a promotes Esophagus Adenocarcinoma aggressiveness. On one hand, mir‐196a targets the valosin‐containing protein (VCP) mRNA, causing the accumulation of c‐MYC protein that leads to high amounts of TERT. On the other hand, mir‐196a targets the inhibitor of NFκB (NFKBIA).
Jesús García‐Castillo, Carlos M. Martínez‐Cáceres, Manuel Bernabé‐García, Vicente Munitiz, David Ruiz de Angulo, Pascual Parrilla, Ángeles Ortiz, Luisa F. Martínez de Haro, María L. Cayuela   +8 more
wiley   +1 more source

The homogeneity of training for graduate students of psychiatry in different universities in China. [PDF]

BMC Med Educ
Yuan-Hong S, Xia G, Yang L, Ping T.
europepmc   +1 more source

The Effect of Sex Hormones on Experimental Trichophyton Purpureum Infection in Rabbits11From the Dept. of Medicine (Dermatology), New York Hospital, Cornell University Medical College. This investigation was supported by a grant from the Dazien Foundation for Medical Research. Schering Corporation kindly furnished the hormonal preparations.

, 1947
Frederick Reiss
openalex   +1 more source

Communications from the physical laboratory of the University of Leiden [PDF]

, 1900
G. Ercolini
openalex   +1 more source

The anticancer effect of the HDAC inhibitor belinostat is enhanced by inhibitors of Bcl‐xL or Mcl‐1 in ovarian cancer

Molecular Oncology, EarlyView.
The pan‐HDAC inhibitor belinostat increases the expression of the pro‐apoptotic proteins Bim, Puma, and Noxa and induces apoptosis in ovarian cancer cell lines and patient‐derived tumor organoids when used at high concentrations. Moreover, inhibiting the anti‐apoptotic proteins Bcl‐xL or Mcl‐1 sensitizes these preclinical models to the cytotoxic effect
Cécilia Thomine, Sterenn Guillemot, Louis‐Bastien Weiswald, Romane Florent, Edwige Abeilard, Florence Giffard, Emilie Brotin, Mélanie Briand, Enora Dolivet, Laurent Poulain, Marie Villedieu   +10 more
wiley   +1 more source

Exclusion and inequity: a national analysis of disability-inclusive admission criteria in Saudi medical schools. [PDF]

Front Med (Lausanne)
Sayed AA.
europepmc   +1 more source

The Colloidal State as a Stimulus for Non-Allergic Epithelioid Granulomas: Experimental Studies in Man with Pure Sodium Stearate and Palmitate11From the Department of Dermatology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

, 1959
Harry J. Hurley, Walter B. Shelley
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Two decades of accreditation in Chilean medical education: outcomes and lessons learned. [PDF]

BMC Med Educ
Yañez OJ, Carter CS, Rivas MA, García BC.   +3 more
europepmc   +1 more source